Gould Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $218K | Buy |
9,062
+1,283
| +16% | +$33.6K | 0.03% | 167 |
|
|
2026
Q1 | $218K | Buy |
+7,779
| New | +$207K | 0.04% | 165 |
|
|
2025
Q4 | – | Sell |
-14,204
| Closed | -$362K | – | 176 |
|
|
2025
Q3 | $362K | Sell |
14,204
-985
| -6% | -$24.3K | 0.07% | 129 |
|
|
2025
Q2 | $368K | Sell |
15,189
-25
| -0.2% | -$583 | 0.07% | 122 |
|
|
2025
Q1 | $386K | Buy |
15,214
+25
| +0.2% | +$654 | 0.08% | 115 |
|
|
2024
Q4 | $403K | Sell |
15,189
-634
| -4% | -$17.2K | 0.08% | 112 |
|
|
2024
Q3 | $458K | Buy |
15,823
+6,110
| +63% | +$178K | 0.1% | 101 |
|
|
2024
Q2 | $272K | Hold |
9,713
| – | – | 0.06% | 134 |
|
|
2024
Q1 | $270K | Hold |
9,713
| – | – | 0.07% | 134 |
|
|
2023
Q4 | $280K | Sell |
9,713
-75
| -0.8% | -$2.27K | 0.07% | 124 |
|
|
2023
Q3 | $325K | Sell |
9,788
-25
| -0.3% | -$884 | 0.09% | 112 |
|
|
2023
Q2 | $360K | Buy |
9,813
+169
| +2% | +$6.58K | 0.1% | 101 |
|
|
2023
Q1 | $393K | Sell |
9,644
-7,625
| -44% | -$329K | 0.11% | 93 |
|
|
2022
Q4 | $885K | Sell |
17,269
-95
| -0.5% | -$4.55K | 0.27% | 46 |
|
|
2022
Q3 | $760K | Buy |
17,364
+584
| +3% | +$28.4K | 0.26% | 43 |
|
|
2022
Q2 | $880K | Buy |
16,780
+830
| +5% | +$42.3K | 0.28% | 39 |
|
|
2022
Q1 | $826K | Sell |
15,950
-1,853
| -10% | -$96.1K | 0.24% | 44 |
|
|
2021
Q4 | $1.05M | Sell |
17,803
-50
| -0.3% | -$2.48K | 0.29% | 37 |
|
|
2021
Q3 | $768K | Sell |
17,853
-10,323
| -37% | -$457K | 0.24% | 45 |
|
|
2021
Q2 | $1.1M | Hold |
28,176
| – | – | 0.31% | 45 |
|
|
2021
Q1 | $1.02M | Sell |
28,176
-200
| -0.7% | -$7.1K | 0.31% | 44 |
|
|
2020
Q4 | $1.04M | Sell |
28,376
-874
| -3% | -$32.1K | 0.32% | 44 |
|
|
2020
Q3 | $1.02M | Hold |
29,250
| – | – | 0.34% | 39 |
|
|
2020
Q2 | $907K | Sell |
29,250
-179
| -0.6% | -$6.08K | 0.32% | 42 |
|
|
2020
Q1 | $911K | Hold |
29,429
| – | – | 0.35% | 39 |
|
|
2019
Q4 | $1.09M | Sell |
29,429
-624
| -2% | -$22.2K | 0.36% | 40 |
|
|
2019
Q3 | $1.02M | Hold |
30,053
| – | – | 0.36% | 40 |
|
|
2019
Q2 | $1.24M | Hold |
30,053
| – | – | 0.45% | 36 |
|
|
2019
Q1 | $1.21M | Sell |
30,053
-131
| -0.4% | -$5.25K | 0.45% | 35 |
|
|
2018
Q4 | $1.25M | Hold |
30,184
| – | – | 0.52% | 29 |
|
|
2018
Q3 | $1.26M | Buy |
30,184
+276
| +0.9% | +$10.6K | 0.5% | 32 |
|
|
2018
Q2 | $1.03M | Sell |
29,908
-454
| -1% | -$15.5K | 0.44% | 32 |
|
|
2018
Q1 | $1.02M | Buy |
30,362
+1,692
| +6% | +$58.2K | 0.45% | 33 |
|
|
2017
Q4 | $985K | Sell |
28,670
-2,214
| -7% | -$75.5K | 0.43% | 39 |
|
|
2017
Q3 | $1.05M | Buy |
30,884
+1,740
| +6% | +$55.9K | 0.47% | 35 |
|
|
2017
Q2 | $929K | Sell |
29,144
-57
| -0.2% | -$1.8K | 0.45% | 35 |
|
|
2017
Q1 | $948K | Buy |
29,201
+2,379
| +9% | +$75K | 0.48% | 32 |
|
|
2016
Q4 | $827K | Sell |
26,822
-316
| -1% | -$9.65K | 0.42% | 33 |
|
|
2016
Q3 | $872K | Buy |
27,138
+632
| +2% | +$21.1K | 0.47% | 32 |
|
|
2016
Q2 | $885K | Sell |
26,506
-3,974
| -13% | -$127K | 0.47% | 30 |
|
|
2016
Q1 | $857K | Hold |
30,480
| – | – | 0.46% | 30 |
|
|
2015
Q4 | $933K | Buy |
30,480
+230
| +0.8% | +$7.24K | 0.5% | 27 |
|
|
2015
Q3 | $901K | Sell |
30,250
-659
| -2% | -$21.1K | 0.5% | 29 |
|
|
2015
Q2 | $983K | Buy |
30,909
+1,070
| +4% | +$34.9K | 0.5% | 29 |
|
|
2015
Q1 | $985K | Hold |
29,839
| – | – | 0.48% | 32 |
|
|
2014
Q4 | $882K | Buy |
29,839
+2,108
| +8% | +$60.4K | 0.43% | 36 |
|
|
2014
Q3 | $778K | Hold |
27,731
| – | – | 0.38% | 41 |
|
|
2014
Q2 | $781K | Hold |
27,731
| – | – | 0.38% | 40 |
|
|
2014
Q1 | $845K | Sell |
27,731
-3,735
| -12% | -$111K | 0.45% | 35 |
|
|
2013
Q4 | $914K | Buy |
31,466
+343
| +1% | +$9.98K | 0.53% | 26 |
|
|
2013
Q3 | $848K | Sell |
31,123
-385
| -1% | -$10.5K | 0.53% | 25 |
|
|
2013
Q2 | $837K | Buy |
+31,508
| New | +$871K | 0.52% | 23 |
|
Other funds holding PFE
Gould Asset Management's PFE Position: Q2 2026 in Review
Gould Asset Management increased its Pfizer (PFE) stake by 16% in Q2 2026, buying an estimated $33.6K and bringing the position to 9,062 shares worth $218K. The position accounts for 0.03% of the portfolio, ranked #167.
Gould Asset Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.26M in Q3 2018. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Gould Asset Management held 9,062 shares of Pfizer worth $218K as of Q2 2026.
- Gould Asset Management bought 1,283 Pfizer shares in Q2 2026, an estimated $33.6K.
- Pfizer made up 0.03% of Gould Asset Management's portfolio in Q2 2026, its #167 holding.
- Gould Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Gould Asset Management's Pfizer position peaked at $1.26M in Q3 2018.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Gould Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.